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Abstract: Glomerular filtration rate is controlled by the contractile effect of angiotensin II
on afferent and efferent arterioles. The renin positivity of the afferent arterioles depends on
tubuloglomerular feedback via the macula densa (MD) and short loop feedback via the
afferent arteriolar endothelia. The renin-producing cells are trans-differentiated from smooth
muscle cells (SMCs) of mainly the afferent arterioles, the MD cells are trans-differentiated
from the neighboring tubular cells, and the high-permeability endothelial cells are trans-
differentiated from normal permeability endothelial cells facing the renin-negative part of the
afferent arterioles. All of the trans-differentiations depend on the activity of the renin-
angiotensin system (RAS). The distribution of AT1 receptors for angiotensin II expresses
the contractile effects of angiotensin II on renin-negative SMCs and the negative effect on
trans-differentiation of renin-positive SMCs and MD cells. The purpose of this review is to
summarize the stereological data of molecules like angiotensin II AT1 receptors, L-type
calcium channels, and renin receptors in the juxtaglomerular apparatus of normal and STZ-
induced diabetic rat kidneys, thus showing their functional relevancies on trans-differentia-
tion among the juxtaglomerular apparatus’ elements.
Keywords: angiotensin II, renin, trans-differentiation, kidney, arteriole, afferent arteriole,
efferent arteriole, tubuloglomerular feedback, macula densa
Introduction
The elements of the juxtaglomerular apparatus (JGA) are well defined, while their
stereological behaviors are not well characterized. The JGA is a functional unit, but
it has no defined length, size or volume.1
The glomerular fluid flow and filtration pressure result in a glomerular filtration rate,
which is controlled by the tone of the afferent and efferent arterioles. The contraction of
afferent arterioles decreases glomerular flow and filtration pressure, in opposition to the
contraction of efferent arterioles where the glomerular flow is decreased, but the glo-
merular filtration pressure is increased.2 The main agonist of arteriolar contraction is
angiotensin II via the angiotensin II AT1 receptors.3 Glomerular fluid flow and filtration
pressure are under the control of the renin-angiotensin system (RAS).
The main sources of renin for glomerular fluid flow and filtration pressure are
the renin-granulated parts of the afferent arterioles. Actual renin granulation in
afferent arterioles depends on the balance of trans-differentiation between the renin-
positive and renin-negative SMCs. This trans-differentiation is determined by the
balance of osmotic pressure in the JGA, thus it is under the control of the RAS.4,5
The osmotic balance in the JGA is dependent on the fluid flow in this area.
Tubuloglomerular feedback via the macula densa (MD) and short loop feedback via
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the afferent arteriolar endothelium are the two pathways
that affect the fluid flow characteristics of the JGA.4
Tubuloglomerular feedback depends on a balance of
trans-differentiation between the MD cells and the neigh-
boring tubular cells.1 Short loop feedback depends on a
balance of trans-differentiation between the high-perme-
ability endothelial cells facing the renin-positive area of
the afferent arterioles and the normal permeability
endothelial cells of the afferent arterioles. Both of the
trans-differentiations are under the control of the RAS.5
The RAS control of trans-differentiation between
renin-positive and renin-negative SMCs is expressed by
the negative effects of angiotensin II on renin granulation.
Treatment with angiotensin II AT1 receptor antagonists
increases renin granulation.4,6
In diabetes, the balance of trans-differentiation
between renin-positive and renin-negative SMCs exhibits
elevated renin granulation in afferent arterioles, while the
kidney tissue level of angiotensin II is also elevated.7,8
This discrepancy is a particularity of diabetes, in which the
number of angiotensin II AT1 receptor subtypes are esti-
mated using stereological principles in afferent and effer-
ent arterioles as renin-positive SMCs and renin-negative
SMCs makes out it.9
The purpose of this review is to summarize the stereo-
logical data of some molecules involved in the JGA.
Levels of angiotensin II AT1 receptors, L-type calcium
channels, and renin receptors are related to the trans-dif-
ferentiation of high-permeability and normal permeability
endothelial cells of arterioles, or the trans-differentiation
of renin-positive and renin-negative SMCs, or the trans-
differentiation of macula densa and neighboring tubular
cells in normal and STZ-induced diabetic rat kidneys. The
stereological data is used to show the functional relevan-
cies of some molecules found in the JGA.
Method
Measurement of permeability of endothelia was performed
on full length of afferent arterioles. The stereological
method was used at TEM level for mapping the amount
of tracers along the wall of arterioles.10 The experimental
diabetes was performed with streptozotocin using standard
protocol.9 Measurement of angiotensin II level was per-
formed in blood and kidney tissue by ELISA.9 The BrdU
test and Ki67 immunohistochemistry were performed to
detect the proliferation.1 The same labeling system was
used for different antibodies (AT1 receptors; L-type Ca
channel (pro)renin receptors). Where the distribution of
immunohistochemical signal along the arterioles were esti-
mated by using the stereological principles as described at
2006.11
Discussion
Trans-Differentiation Between the
Afferent Arteriolar High- and Normal
Permeability Endothelia
Permeability of Afferent Arteriole
The afferent arterioles, defined as pre-glomerular arterioles
from the glomerulus to first branching, consist of two
types of endothelia. It exhibits fenestration facing the
extra-glomerular mesangial cells.4 The permeability of
the afferent arteriolar endothelium increases with close-
ness to the glomerulus. The location of this endothelium
corresponds to the renin-positive part of the afferent arter-
iole. After treatment with the angiotensin II antagonist,
candesartan, the length of the high-permeability portion
of the endothelium along the afferent arteriole increased.
When estimating the length of the higher permeability
portion of the endothelium and the renin-positive part of
the afferent arteriole, a correlation was found between
endothelial permeability and renin-positivity.5 The higher
permeability endothelia facing the renin-positive part of
the afferent arteriole are trans-differentiated from the nor-
mal endothelia located on the renin-negative part. The
trans-differentiation of endothelia is under the control of
the RAS.5
The endothelial permeability is related to the Ca2+
level. Higher Ca2+ levels in the endothelial cell result in
higher permeability of micro vessels.12 In normal kidneys,
the L-type Ca2+ channels are downregulated in the
endothelial cells facing the renin-positive part of the affer-
ent arterioles. These downregulations are not present in
STZ-induced diabetic rat kidneys.13 This regulation of
L-type Ca2+ channels in afferent arterioles of normal and
diabetic rats shows the Ca2+ channel may well be related
to trans-differentiation between the high and normal per-
meability endothelia of afferent arterioles.13
Trans-Differentiation Between Renin-
Positive and Renin-Negative SMCs of
Afferent Arterioles
The afferent arterioles have two parts. The renin-positive
SMCs and actin-negative SMCs are found close to the
glomerulus, beyond this part there are the renin-negative
Razga Dovepress
submit your manuscript | www.dovepress.com
DovePress
International Journal of Nephrology and Renovascular Disease 2020:13148
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f N
ep
hr
ol
og
y 
an
d 
R
en
ov
as
cu
la
r 
D
is
ea
se
 d
ow
nl
oa
de
d 
fr
om
 h
ttp
s:
//w
w
w
.d
ov
ep
re
ss
.c
om
/ b
y 
16
0.
11
4.
97
.1
83
 o
n 
06
-N
ov
-2
02
0
F
or
 p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
SMCs and actin-positive SMCs. The lengths of the two
can vary over a lifetime.14
Distribution of Angiotensin II AT1 Receptors in
Kidney Arterioles of Normal Rats
Estimation of the immunohistochemical signals of angio-
tensin II AT1 receptor on afferent and efferent arteriole
profiles does not show any differences in SMCs and
endothelial cells along the arterioles. Nonetheless, between
the renin-positive SMCs and renin-negative SMCs signifi-
cant differences were found, where angiotensin II AT1
receptors in renin-positive cells were downregulated com-
pared to renin-negative SMCs.6 The same stereological
estimation of angiotensin II AT1-A and AT1-B receptors
in arterioles clarified that the trans-differentiation between
the renin-positive SMCs and renin-negative SMCs is regu-
lated by angiotensin II binding angiotensin II AT1-A
receptors (Figure 1).15
Between the afferent and efferent arterioles a 27.5%
difference in angiotensin II AT1 receptors was found, but it
is not significant.6 When estimating the angiotensin II AT1
receptor subtypes separately, significant differences were
found in the relative number of angiotensin II AT1-B recep-
tors between the afferent and efferent arterioles (Figure 2).15
The differences in the contractile effects of angiotensin II
between the afferent and efferent arterioles are expressed in
the number of angiotensin II AT1-B receptors.
Distribution of Angiotensin II AT1 Receptors on
Kidney Arterioles in STZ-Induced Diabetic Rats
Insulin upregulates AT1 receptor gene expression in cell
cultures of vascular SMCs. Higher levels of AT1 receptor
result in enhanced responses of the vascular SMCs to angio-
tensin II.16,17 In STZ-induced diabetes, AT1-A and AT1-B
are downregulated in the afferent and efferent arterioles.
These downregulations are extreme and heterogeneous.9 In
this experiment, diabetes is shown with elevated blood sugar
levels at tenweeks, with normal angiotensin II tissue levels in
the kidney. These parameters are evidence that angiotensin II
receptor downregulation is independent from angiotensin II
levels.9
In diabetic rats, the angiotensin II level in the kidney is
elevated compared to normal rats,7,18,19 however the level of
renin granulation in the afferent arterioles is also higher than
normal.8 In diabetic rats, angiotensin II AT1-A and AT1-B
receptors are downregulated on both the renin-positive and
renin-negative SMCs surfaces (Figure 3A and B).9 The
difference in the number of AT1-A receptors between the
Figure 1 The relative number of angiotensin II AT1-B receptors on the SMCs of normal kidney arterioles (single values + mean, Mann–Whitney test). Reproduced with
permission from Razga Z, Nyengaard JR. Up- and down-regulation of angiotensin II AT(1)-A and AT(1)-B receptors in afferent and efferent rat kidney arterioles. Journal of
the Renin-Angiotensin-Aldosterone System 2008; 9: 196–201. Copyright © 2008, © SAGE Publications.15 The significant differences of AT1 receptors between the afferent
end efferent arterioles are expressed the different contractile character of arterioles related with AT1-B receptors.
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renin-positive and renin-negative SMCs is same as in normal
rats, the downregulation of AT1-B are enhanced in the renin-
positive than in renin-negative SMCs (Figure 3A and B). The
number ofAT1 (AT1-A+AT1-B) receptors is lower in diabetic
rats. A possible reason for high-level trans-differentiation of
renin-positive SMCs from renin-negative SMCs with high
levels of angiotensin II might be the attached downregulation
of the AT1-B receptors of SMCs.9
Distribution of (Pro)renin Receptors in Arteriolar
SMCs of Normal Rats
The (pro)renin receptors are localized on cell surfaces and in
parts of the cytoplasm. In the kidney, the (pro)renin receptors
are shown by immunohistochemistry in glomerular mesangial
and epithelial cells, vascular SMCs of arteries, and in distal
and collecting tubular cells.20–22 In neonates, the (pro)renin
receptors have enhanced expression, supporting the theory that
the (pro)renin receptors play a role in kidney development.23
Stereological estimation of (pro)renin receptors suggested that
the relative number (pro)renin receptors were upregulated on
the surface of renin-positive SMCs compared to renin-nega-
tive SMCs and downregulated in the cytoplasm of renin-
positive SMCs compared to renin-negative SMCs (Figures 4
and 5).24 The distribution of (pro)renin receptors is related to
trans-differentiation between renin-positive SMCs and renin-
negative SMCs of the afferent arterioles.24
Distribution of (Pro)renin Receptors in Arteriolar
SMCs of STZ-Induced Diabetic Rats
The relative number of (pro)renin receptors in kidney arterioles
was estimated in STZ-induced diabetic rats, where the angio-
tensin II kidney level does not show any changes compared to
normal. No pathomorphological changes were found in the
glomerulus nor in increments of renin granulation of arterioles.
However (pro)renin receptors were distributed differently in
afferent arterioles compared to normal. The redistribution of
(pro)renin receptors resulted in the significant differences
between the renin-positive SMCs and renin-negative SMCs
were equalized in diabetic kidneys. The redistributions were
not related to angiotensin II plasma or kidney levels.24
Distribution of L-Type Calcium Channels in Arteriolar
SMCs of Normal and STZ-Induced Diabetic Rats
Calcium channel blockers, such as nifedipine, diltiazem, and
nitrendipine, cause vasodilatation mainly on the afferent arter-
ioles. This effect on the arteriolar SMCs includes
significant increases in glomerular filtration rate and renal
Figure 2 The relative number of angiotensin II AT1-A receptors on renin-positive and renin-negative SMCs of normal afferent arterioles (single values + mean, Mann–
Whitney test). Reproduced with permission from Razga Z, Nyengaard JR. Up- and down-regulation of angiotensin II AT(1)-A and AT(1)-B receptors in afferent and efferent
rat kidney arterioles. Journal of the Renin-Angiotensin-Aldosterone System 2008; 9: 196–201. Copyright © 2008, © SAGE Publications.15 This significant differences of AT1
receptors show the trans-differentiation between the renin-positive and renin-negative SMCs related to angiotensin II AT1-A receptors subtype.
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blood flow.25 The Ca2+ level of the intracellular and extracel-
lular spaces of afferent arterioles are affiliated to the release of
renin.26 Renin secretion is inhibited by T-type Ca2+ channel
blockers, whereas L-type blockers have the opposite effect.27
In the normal kidney, estimation of relative numbers of L-type
Ca2+ channels does not show any significant difference in
arteriolar renin-positive and renin-negative SMCs.13 This
result does not support any relationship between the trans-
differentiation of renin-positive and renin-negative SMCs
and L-type Ca2+ channels in normal kidneys. But in diabetic
kidneys, the relative number of L-type Ca2+ channels are
upregulated in renin-positive SMCs, causing a significant
Figure 3 In STZ-induced diabetes, the angiotensin II AT1 receptors are downregulated in both renin-positive and renin-negative SMCs of kidney arterioles. Adapted from
Razga Z, Kovacs G, Bodi N, Talapka P, Nyengaard JR. Heterogeneous downregulation of angiotensin II AT1-A and AT1-B receptors in arterioles in STZ-induced diabetic rat
kidneys. Biomed Res Int. 2014;2014:1–6. the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/).9 In diabetes the main morphological
changes the high renin granulation with the high angiotensin II level in kidney tissue. This apparent discrepancy was resolved by finding the downregulation of angiotensin II
AT1-A receptors (A). The downregulation of angiotensin II AT1-B receptors showed the contractile behavior of both arterioles were changed to abnormal in diabetes (B).
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Figure 4 The number of renin receptors on the surface of afferent arteriolar SMCs. Adapted from Razga Z, Kovacs G, Bódi N, Talapka P, Bagyánszki M. Regulation of (Pro)
Renin receptor in renin-positive smooth muscle cells of kidney arterioles in rats with STZ-induced diabetes. Int J Nephrol. 2019;2019:6. Creative Commons Attribution
License (https://creativecommons.org/licenses/by/4.0/).24 Significant difference was found in relative number of renin receptors between the renin-negative and renin-positive
SMCs in normal, but not in diabetes. This difference expressed the renin receptor related to renin granulation that is the trans-differentiation between the renin-positive and
renin-negative SMCs in normal. But in diabetes this difference is not presented which was showed the pathological state was processed from normal.
Figure 5 The number of renin receptors in the cytoplasm of afferent arteriolar SMCs. Adapted from Razga Z, Kovacs G, Bódi N, Talapka P, Bagyánszki M. Regulation of (Pro)
Renin receptor in renin-positive smooth muscle cells of kidney arterioles in rats with STZ-induced diabetes. Int J Nephrol. 2019;2019:6. Creative Commons Attribution
License (https://creativecommons.org/licenses/by/4.0/).24 The same distribution is presented as in surface of SMCs. The renin receptors in cytoplasm of SMCs are related to
trans-differentiation of renin-granulated cells from SMCs.
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difference between the renin-positive and renin-negative
SMCs.13 The upregulation of L-type Ca2+ channels in renin-
positive SMCs in diabetic kidneys could be related to a higher
state of renin granulation in arterioles of diabetic kidneys as a
result of the trans-differentiation between the renin-positive
SMCs and renin-negative SMCs.13
Trans-Differentiation of Macula Densa
from Neighboring Tubular Cells
The MD is modified epithelial cells of the distal tubule
facing the vascular pole of glomerulus.28 The morphol-
ogy of MD cells differs in several ways from neighbor-
ing tubular cells. They have a prismatic shape, poorly-
developed lateral cytoplasm and protrude into the tubu-
lar lumen with palisade nuclei.28 There is significant
correlation between the basal area of the MD and the
contact area between the Goormagtigh field and the
MD.29,30 Considerable enlargement of the MD was
found in Bartter’s syndrome. The different morphology
of MD from neighboring tubular cells signals the differ-
ent, specialized function, where the size of MD may be
changed.31
Total Volume of Macula Densa
By estimating the volume of macula densa in normal kidneys
and after the treatment with angiotensin II AT1 receptor
antagonist candesartan, it was revealed that the volume of
MD increased significantly.1 The volume of MD cells did not
change,1 rather the increase in MD volume was caused by an
increase inMD cell number. The proliferation ofMD cells was
excluded from the immunohistochemistry by using bromo-
deoxyuridine (BrdU) and Ki67. The increase of MD volume
was caused by trans-differentiation of MD cells from neigh-
boring tubular cells. This trans-differentiation was inhibited by
angiotensin II via the AT1 receptors (Figures 6–8).1
Distribution of Angiotensin II AT1receptros on
Macula Densa
The MD releases some molecules, like cyclooxygen-
ase-2 (COX2), prostaglandin-E2 (PgE2), Ca2+, and
neuronal nitric oxide (nNOS), which are involved in
tubuloglomerular feedback. There are interspecies dif-
ferences in the COX2 positivity of MD. In humans,
COX2 is present in SMCs of afferent arterioles instead
of MD.32 In rats, COX2 appears in the MD.33,34 Since
angiotensin II inhibits COX2 positivity via the AT1
Figure 6 The total volume of MD in control and candesartan-treated groups. After treatment with candesartan the volume of MD increased (Paired T-test; p<0.007) by
increasing the number of MD cells. Reproduced with permission from Razga Z, Nyengaard JR. The effect of angiotensin II on the number of macula densa cells through the
AT1 receptor. Nephron Physiology 2009; 112: 37–43. Copyright © 2009, © 2009 S. Karger AG, Basel.1 The total volume of MD is could be changed in the life related to the
activity of RAS.
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Figure 8 The volume of MD cells in the control and candesartan-treated groups. There are no significant differences between the two group. Reproduced with permission
from Razga Z, Nyengaard JR. The effect of angiotensin II on the number of macula densa cells through the AT1 receptor. Nephron Physiology. 2009; 112: 37–43. Copyright ©
2009, © 2009 S. Karger AG, Basel.1 The size of MD cells were not changed, while the volume of MD increased by treatment of candesartan. This is evidence for increment of
MD caused by increment of number of MD cells related to activity of RAS.
Figure 7 The total number of MD cells in control and candesartan-treated groups. There is a significant increase in the candesartan-treated group vs the control (Paired T-test;
p<0.011). Reproduced with permission from Razga Z, Nyengaard JR. The effect of angiotensin II on the number of macula densa cells through the AT1 receptor. Nephron
Physiology. 2009; 112: 37–43. Copyright © 2009, © 2009 S. Karger AG, Basel 0.1 The changes of total volume of MD are a changes in number of MD cells related to activity of RAS.
The proliferation of MD cells was excluded by immunohistochemistry of Ki67 and BrdU test,1 so the changes in number of MD cells are the trans-differentiation related process.
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receptor,35 the activity of angiotensin II should be
reduced in MD.1 If MD cells trans-differentiated from
neighboring COX2 negative tubular cells,28 according
to our hypothesis there should be a significant differ-
ence in the number of angiotensin II AT1 receptors.
This theory was supported by the results of our estima-
tion of the number of angiotensin II AT1 receptors on
surface of macula densa and normal tubular cells
facing the macula densa. Where it was found that the
number of AT1 receptors was significantly reduced on
MD cell surfaces compared to neighboring normal tub-
ular cells (Table 1). This state of AT1 receptor distri-
bution is similar to renin-positive SMCs and renin-
negative SMCs of afferent arterioles. Both the trans-
differentiation of MD cells and renin-granulated cells
are under RAS control.1
Angiotensin II, TGFβ and Trans-
Differentiation
Angiotensin II attenuates the TGFβ induced trans-differ-
entiation via the angiotensin II AT1 receptors.36,37 Any
physiological or pathophysiological pathway makes the
changes in the salt and water balance like using the
mineral corticoids, diuretics and water deplete, etc.,
induce the trans-differentiation indirect manner by the
changing the activity of RAS. The pharmacological
effect on activity of RAS with angiotensin II AT1 recep-
tor blocker, ACE blocker or renin antagonist induce the
trans-differentiation on juxtaglomerular apparatus indir-
ect manner too. The TGFβ pathway attenuated by angio-
tensin II through the AT1 receptors are the primary
mechanism of trans-differentiation in juxtaglomerular
apparatus. Any physiological or pharmacological effect
on activity of RAS could generate the trans-differentia-
tion of element of juxtaglomerular apparatus indirectly.
Conclusion
The trans-differentiation of endothelial cells, renin-granu-
lated cells and MD cells are an important mechanism in
the functionality of the JGA in normal and in experimental
diabetes. The three molecules, angiotensin II AT1 (AT1-A
and At1-B) receptors, L-type calcium channels and (pro)
renin receptors play important roles in the trans-differen-
tiation of the different cells types of the JGA element in
the tubules or arterioles of the kidney. The trans-differen-
tiation of all the cell types are under RAS control, but
independent of the angiotensin II plasma or kidney levels
in normal and diabetic rats.
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